University of Dundee aids AI research for hypertension
March 29, 2023Medical Communications
The University of Dundee has announced its involvement in a Europe-wide project which will study whether AI can improve the …
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
March 28, 2023Business Services
OXFORD, United Kingdom, March 28, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …
Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
March 28, 2023Business Services
Milan, Italy, March 28, 2023, 12:30 pm CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …
TEZSPIRE▼(TEZEPELUMAB) TO BE RECOMMENDED BY NICE AS AN ADD-ON TREATMENT FOR SEVERE UNCONTROLLED ASTHMA
March 28, 2023Business Services
London, UK, Tuesday 28 March 2023 – AstraZeneca today announced that the National Institute for Health and Care Excellence (NICE) …
Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV
March 28, 2023Business Services
ST. GALLEN, Switzerland, March 28, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that …
iOnctura awarded UK’s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP)
March 28, 2023Business Services
Geneva, Switzerland and Amsterdam, The Netherlands, 28 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …
Sofinnova Partners launches Digital Medicine Strategy
March 28, 2023Business Services
PARIS, France – March 28, 2023 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in …
Vantage Nutrition LLC acquires ComboCap Inc
March 28, 2023Business Services
Vantage Nutrition, an ACG group company announces full shareholding ownership of ComboCap Inc (USA) and BioCap (South Africa).
Eli Lilly invests $1bn in Limerick manufacturing facilities
March 28, 2023Manufacturing and Production
Pharma company Eli Lilly is increasing its investment in its new manufacturing facilities in Limerick, Republic of Ireland. Today’s announcement …
OctoVent and Orient EuroPharma sign licensing agreement over immunotherapeutic candidate
March 28, 2023Medical Communications
OctoVent, subsidiary of Hepalink Pharmaceutical Group, has entered into a license agreement with Taiwan-based Orient EuroPharma (OEP). The two companies …
Novo Nordisk announces results from phase 3 PIONEER PLUS trial
March 28, 2023Research and Development
Novo Nordisk has announced headline results from the phase 3b PIONEER PLUS trial for the safety and efficacy of once-daily …
GSK shares promising clinical trial results for endometrial cancer therapy
March 28, 2023Research and Development
GSK has announced promising results from part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial for Jemperli (dostarlimab) alongside standard-of-care chemotherapy …
PMGroup announces launch of new recruitment platform PharmaRole
March 28, 2023Business Services
PMGroup Worldwide Ltd (PMGroup) has announced the launch of its new recruitment platform, PharmaRole.com, designed to make it as simple …
Particle Works partners with Earli Inc. to develop DNA-LNPs for early-stage cancer treatment
March 27, 2023Business Services
Particle Works, a leading provider of innovative microfluidic nanoparticle synthesis platforms, is supporting Earli Inc. in its mission to detect, …
Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease
March 27, 2023Business Services
NEW ORLEANS, LA and CAMBRIDGE, England, March 27, 2023 – Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing …
Statement Following Jounce Therapeutics Announcement of a Definitive Merger Agreement with Concentra Biosciences and Withdrawal of their Recommendation for the Business Combination with Redx
March 27, 2023Business Services
Alderley Park, UK 27 March 2023 Redx Pharma (“Redx”, AIM: REDX), the clinical-stage biotechnology company focused on discovering and developing …
MHRA Grants Conditional Marketing Authorisation in Great Britain to CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Haemophilia B
March 27, 2023Business Services
This medicine is subject to additional monitoring.This will allow quick identification of new safety information.
Avacta to present pre-clinical data on AVA3996 at the American Association for Cancer Research Annual Meeting
March 27, 2023Business Services
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces it will …
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
March 27, 2023Business Services
Leiden, The Netherlands, March 24, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the …
Novartis announces positive results from phase 3 trial of Kisqali for early breast cancer
March 27, 2023Research and Development
Novartis has announced positive results from its phase 3 NATALEE trial assessing Kisqali (ribociclib) along with endocrine therapy (ET) in …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
